In addition, higher expression of OGT, FOXC1, ASNS, GPT2, CBS, or FTH1 was also associated with poorer outcomes in clinical cases with renal clear cell carcinoma or glioma (Fig. S12). The gene discussed is CBS; the disease is central nervous system cancer.